Leszek Bidzan

898 total citations
67 papers, 635 citations indexed

About

Leszek Bidzan is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Leszek Bidzan has authored 67 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 10 papers in Neurology and 10 papers in Physiology. Recurrent topics in Leszek Bidzan's work include Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (8 papers) and Neurological Disorders and Treatments (6 papers). Leszek Bidzan is often cited by papers focused on Dementia and Cognitive Impairment Research (17 papers), Alzheimer's disease research and treatments (8 papers) and Neurological Disorders and Treatments (6 papers). Leszek Bidzan collaborates with scholars based in Poland, Italy and United Kingdom. Leszek Bidzan's co-authors include Mariola Bidzan, Maria Pąchalska, Ilona Bidzan-Bluma, Paweł Jurek, Marcus Stueck, David V. Sheehan, Mingjin Yan, Atul R. Mahableshwarkar, Paula L. Jacobsen and A. Schreiner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Psychology.

In The Last Decade

Leszek Bidzan

58 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leszek Bidzan Poland 14 224 169 106 98 88 67 635
Bruno Agustini Australia 13 203 0.9× 104 0.6× 85 0.8× 101 1.0× 69 0.8× 23 915
Rajesh R. Tampi United States 16 366 1.6× 170 1.0× 117 1.1× 152 1.6× 45 0.5× 56 851
Teresa Bobes-Bascarán Spain 15 273 1.2× 208 1.2× 108 1.0× 42 0.4× 84 1.0× 42 711
Yu Lee Taiwan 18 253 1.1× 250 1.5× 75 0.7× 73 0.7× 75 0.9× 77 1.0k
Dalibor Karlović Croatia 19 226 1.0× 272 1.6× 91 0.9× 68 0.7× 76 0.9× 93 1.0k
Marc Agronin United States 13 200 0.9× 199 1.2× 117 1.1× 99 1.0× 24 0.3× 39 758
Awais Aftab United States 15 250 1.1× 155 0.9× 46 0.4× 63 0.6× 68 0.8× 65 765
Christophe Arbus France 16 376 1.7× 207 1.2× 122 1.2× 130 1.3× 93 1.1× 55 903
Alexandra K. Gold United States 15 283 1.3× 207 1.2× 48 0.5× 73 0.7× 169 1.9× 41 772
Blanka Kores Plesničar Slovenia 18 230 1.0× 139 0.8× 81 0.8× 69 0.7× 30 0.3× 51 847

Countries citing papers authored by Leszek Bidzan

Since Specialization
Citations

This map shows the geographic impact of Leszek Bidzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leszek Bidzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leszek Bidzan more than expected).

Fields of papers citing papers by Leszek Bidzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leszek Bidzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leszek Bidzan. The network helps show where Leszek Bidzan may publish in the future.

Co-authorship network of co-authors of Leszek Bidzan

This figure shows the co-authorship network connecting the top 25 collaborators of Leszek Bidzan. A scholar is included among the top collaborators of Leszek Bidzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leszek Bidzan. Leszek Bidzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waszak, Przemysław, et al.. (2025). Underreporting of Adverse Events Following COVID-19 Vaccination Among Healthcare Professionals in Poland: Potential Implications for Vaccine Hesitancy. Tropical Medicine and Infectious Disease. 10(11). 320–320. 1 indexed citations
2.
Bidzan, Leszek, et al.. (2023). Aggressive behavior and prognosis in patients with mild cognitive impairment. Dementia & Neuropsychologia. 17. 1 indexed citations
3.
Waszak, Przemysław, et al.. (2023). Clinical and demographic features of acutely hospitalised schizophrenia patients according to Toxoplasma gondii serostatus. CeON Repository (Centre for Evaluation in Education and Science). 6(1). 14–24. 1 indexed citations
4.
Kubanek, Alicja, et al.. (2023). Use of sertraline and agomelatine in hemodialysis patients: A case series report. Acta Biochimica Polonica. 70(4). 979–983.
5.
Bidzan, Leszek. (2022). Cardiovascular factors in dementia. Psychiatria Polska. 56(5). 991–1001. 1 indexed citations
6.
Bidzan, Leszek, et al.. (2021). Cognitive functions and thyroid hormones secretion disorders. Psychiatria Polska. 55(2). 309–321. 15 indexed citations
7.
Waszak, Przemysław, et al.. (2021). Social Isolation During COVID-19 Pandemic. Perceived Stress and Containment Measures Compliance Among Polish and Italian Residents. Frontiers in Psychology. 12. 673514–673514. 23 indexed citations
8.
Bidzan-Bluma, Ilona, et al.. (2020). A Polish and German Population Study of Quality of Life, Well-Being, and Life Satisfaction in Older Adults During the COVID-19 Pandemic. Frontiers in Psychiatry. 11. 585813–585813. 125 indexed citations
9.
Bidzan, Mariola, Leszek Bidzan, & Ilona Bidzan-Bluma. (2017). Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia. Archives of Medical Science. 5(5). 1168–1177. 17 indexed citations
10.
Lipska‐Ziętkiewicz, Beata S., Magdalena Chmara, Bartosz Wasąg, et al.. (2016). The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms. Alzheimer s Research & Therapy. 8(1). 19–19. 20 indexed citations
11.
Bidzan, Mariola, Leszek Bidzan, & Maria Pąchalska. (2014). Neuropsychiatric symptoms in patients with Alzheimer’s disease with a vascular component. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Bidzan, Mariola, Leszek Bidzan, & Maria Pąchalska. (2014). Neuropsychiatric symptoms in patients with Alzheimer’s disease with a vascular component. Annals of Agricultural and Environmental Medicine. 21(2). 412–415. 13 indexed citations
13.
Heres, Stephan, Leszek Bidzan, Michel Blanc, et al.. (2013). Treatment of acute schizophrenia with paliperidone ER: Predictors for treatment response and benzodiazepine use. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 48. 207–212. 13 indexed citations
14.
Schmauß, Max, Vlado Jukić, Alberto Siracusano, et al.. (2012). Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study. Current Medical Research and Opinion. 28(8). 1395–1404. 13 indexed citations
15.
Bidzan, Leszek, Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, & David V. Sheehan. (2012). Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial. European Neuropsychopharmacology. 22(12). 847–857. 59 indexed citations
16.
Bidzan, Leszek & Mariola Bidzan. (2012). Withdrawal syndrome after donepezil cessation in a patient with dementia. Neurological Sciences. 33(6). 1459–1461. 17 indexed citations
17.
Bidzan, Leszek, et al.. (2010). [Neurobiological expression of the placebo effect].. PubMed. 44(2). 221–34. 1 indexed citations
18.
Bidzan, Leszek, et al.. (2009). Aggressive and impulsive behaviors in Frontotemporal dementia and Alzheimer's disease.. PubMed. 15(5). CR248–54. 11 indexed citations
19.
Bidzan, Leszek, et al.. (2005). [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia].. PubMed. 39(3). 559–66. 2 indexed citations
20.
Bidzan, Leszek, et al.. (2003). [The cognitive deficits in the late-life depression and their prognostic value for pharmacotherapy].. PubMed. 36(6 Suppl). 167–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Agustini Breakdown of academic impact, for papers by Rajesh R. Tampi Breakdown of academic impact, for papers by Teresa Bobes-Bascarán Breakdown of academic impact, for papers by Yu Lee Breakdown of academic impact, for papers by Dalibor Karlović Breakdown of academic impact, for papers by Marc Agronin Breakdown of academic impact, for papers by Awais Aftab Breakdown of academic impact, for papers by Christophe Arbus Breakdown of academic impact, for papers by Alexandra K. Gold Breakdown of academic impact, for papers by Blanka Kores Plesničar
Rankless by CCL
2026